๐ Patanjali Foods Limited Q3 FY25 Financial Analysis & Key Insights ๐
1๏ธโฃ Financial Highlights
๐ Sales Growth
โ
Q3 FY25 Revenue from Operations: โน9,103.13 Cr vs. Q3 FY24: โน7,910.70 Cr โ ๐ +15.07% YoY Growth
โ
9M FY25 Revenue: โน24,430.38 Cr
โ
Segment-wise Performance:
๐ป Edible Oils: โน6,717.47 Cr (+22.5% YoY Growth โ
)
๐ฅ Food & FMCG: โน2,037.61 Cr (๐ Down from โน2,498.62 Cr in Q3 FY24)
๐งด Home & Personal Care (HPC): โน420.36 Cr (๐ข Newly Integrated)
๐ Exports: โน67.27 Cr (Sales in 29 Countries)
๐ฐ Profit Margins & Growth
โ
Q3 FY25 EBITDA: โน581.24 Cr (6.39% Margin) vs. โน390.63 Cr in Q3 FY24 (๐ +48.79% YoY Growth)
โ
9M FY25 EBITDA: โน1,510.17 Cr (6.18% Margin)
โ
Q3 FY25 PAT: โน370.93 Cr (4.06% Margin) vs. โน216.54 Cr in Q3 FY24 (๐ฅ +71.30% YoY Growth)
โ
9M FY25 PAT: โน937.78 Cr (3.84% Margin)
2๏ธโฃ Profitability, Solvency, Liquidity & Valuation ๐
๐ Profitability Ratios
โ Gross Profit (GP) Margin: Increased from โน1,051.44 Cr to โน1,482.00 Cr YoY ๐ (Strong edible oil margins ๐ช)
โ EBITDA Margin: 6.39% (Q3 FY25) vs. 4.9% (Q3 FY24) ๐
โ PAT Margin: 4.06% (Q3 FY25) vs. 2.72% (Q3 FY24) ๐ฅ
๐ฆ Solvency & Liquidity
๐ The company maintains a stable balance sheet โ
๐ Valuation Ratios at CMP โน1,853
Trail Earnings Per Share (EPS): โน31.8 ๐
Trail Price-to-Earnings (Trail P/E) Ratio: ~58.3x ๐ (Premium Valuation โ )
Forward Earnings Per Share (FEPS): โน37 ๐
Forward Price-to-Earnings (F_P/E) Ratio: ~50x ๐ (Premium Valuation but decreasing due to increased earnings โ )
Industry Comparison: Higher than traditional FMCG but in line with premium consumer brands ๐ค
3๏ธโฃ Key Business Highlights ๐
๐ฅ Edible Oil Business
โ Strong profitability: EBITDA of โน364.24 Cr (vs. โน107.67 Cr YoY ๐).
โ Branded edible oils contribute 75% of total edible oil sales.
โ Nutrela Oils growth ๐: +41.9% YoY ๐ฏ.
๐ฝ๏ธ Food & FMCG Performance
โ Sales Decline: Revenue down ๐ from โน2,498.62 Cr (Q3 FY24) to โน2,037.61 Cr (Q3 FY25) due to:
Commodity Price Pressure โ
Overall Weak Demand ๐ธ
โ Biscuits & Confectionery: โน395.37 Cr (+1.64% YoY Growth ๐ช).
โ Honey sales doubled ๐ to โน146.87 Cr.
โ Ghee sales stable at โน355.71 Cr ๐ง.
โ Nutraceuticals Revenue: โน15.09 Cr (+6.88% YoY Growth ๐).
โ Nutrela recognized as "Most Preferred Brand for 2024-25" ๐.
๐งผ Home & Personal Care (HPC) Integration
๐ Added โน420.36 Cr in revenue post acquisition in Nov 2024.
๐ข Marquee Products: Dant Kanti ๐ฆท, Saundarya ๐โโ๏ธ, Herbal Wash ๐ฟ, Kesh Kanti ๐งด.
๐ Advertising spend increased to 2.50% of revenue ๐ข.
๐ด Oil Palm Plantation Expansion
โ Total area under plantation: 87,109 hectares ๐ฟ (46.3% mature).
โ 6,157 hectares added in Q3 FY25 ๐ฑ.
โ New Oil Mills in Arunachal Pradesh & Mizoram ๐ญ.
๐ข Marketing & Branding
โ Celebrity Endorsements ๐ค:
MS Dhoni ๐ (Mahakosh & Sunrich).
Shilpa Shetty ๐งโโ๏ธ (Wellness).
Shahid Kapoor ๐ฌ (Nutrela).
Khesari Lal Yadav ๐ค (Regional Outreach).
4๏ธโฃ Near-Term & Long-Term Outlook ๐ฎ
๐ Near-Term (1-2 Quarters)
โ Challenges:
โ Weak FMCG Demand (Urban consumption slowdown) ๐ธ.
โ Commodity Price Volatility (Edible oils, wheat, sugar) ๐.
โ Higher Marketing & Advertising Spend (May impact short-term profitability) ๐ข.
โ
Opportunities:
โ Edible Oils remain a strong driver ๐ช.
โ HPC integration can improve margins ๐ฐ.
โ Increased market penetration via celebrity branding ๐ข.
๐ Long-Term (1-3 Years)
๐ Growth Drivers:
โ Transition into a full-scale FMCG giant ๐ญ.
โ Oil palm plantations offer long-term cost benefits ๐ฑ.
โ E-commerce & modern trade expansion ๐ฆ.
โ Export market expansion ๐.
โ Risks & Challenges:
โ Heavy dependence on Edible Oil (~75% of revenue) ๐ญ.
โ Regulatory risks in FMCG (Food Safety, Ad Bans, etc.) ๐ซ.
โ High Competition from FMCG giants (HUL, ITC, Dabur, Nestlรฉ) โ.
๐ฏ Final Verdict
โ
Short-term: Strong profit growth ๐ฅ led by Edible Oils, but weak FMCG demand โ remains a concern.
โ
Long-term: Transitioning into a pure-play FMCG player ๐ฏ with brand investments, HPC integration, & oil palm expansion ๐ฟ.
โ
Valuation Check: At โน1,853, the stock is trading at ~58x P/E. Expensive vs. peers, but high growth potential ๐.
๐ข Disclaimer & Disclosure Statement
Important Investor Advisory Notice
This research analysis is for informational purposes only and should not be considered as financial, investment, or legal advice. The information provided herein is based on publicly available financial reports, market data, and our analysis. Investors are advised to exercise caution and discretion before making any investment decisions.